Chemours, a leader in titanium dioxide sector, also excels in new refrigerants like Opteon due to regulatory changes. See why ...

Chemours’s ( NYSE: CC) stock on Tuesday rose as much as 4.1% after the chemicals maker reported a smaller loss for the fourth ...

Q4 2024 Earnings Call Transcript February 18, 2025 The Chemours Company beats earnings expectations. Reported EPS is $0.11, ...

Chemours Co. has initiated a strategic review of its European fluoropolymer production assets, including plants in Mechelen, ...

Developed to address an evolving regulatory climate and deliver solutions that meet customer needs, Ti-Pure™ TS-6706 is part of the Chemours Ti-Pure™ Sustainability Series (TS), dedicated to ...

Chemours Company reports Q4 net sales of $1.359 billion, in line with consensus. Adjusted EBITDA improved 2% Y/Y. FY25 ...

Strategic Financial Concepts LLC purchased a new stake in shares of The Chemours Company (NYSE:CC – Free Report) during the ...

I would like to welcome everyone to the Chemours Company fourth quarter 2024 research results conference call. (Operator Instructions) I would like to remind everyone that this conference call is ...

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 10 cents per share. The chemical company posted revenue of $1 ...

The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and ...

Company announces the launch of Ti-Pure TS-6706, a TMP- and TME- free version of Ti-Pure R-706 – the benchmark, universal ...

BMO Capital analyst John McNulty lowered the firm’s price target on Chemours (CC) to $27 from $34 and keeps an Outperform rating on the shares ...